NCT04187209View on ClinicalTrials.gov

Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

January 13, 2021

Study Completion Date

January 13, 2021

Conditions
StrokeStroke, AcuteStroke, SubacuteRobotics
Interventions
DEVICE

Use of the Atalante exoskeleton

A session includes a stand-up, walks over a distance of 10 meters, exercises with or without the assistance of the exoskeleton, U-turns and a sitting.

Trial Locations (3)

56270

Centre mutualiste de Rééducation et de Réadaptation de Kerpape, Ploemeur

62600

Centre Jacques Calvé - Fondation Hopale, Berck

63330

Centre de Médecine Physique et de Réadaptation de Pionsat, Pionsat

All Listed Sponsors
lead

Wandercraft

INDUSTRY

NCT04187209 - Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months). | Biotech Hunter | Biotech Hunter